Search

everythinglearnresearchcommunity

for

Search:↓

Breezula® may be more effective than Minoxidil in promoting hair growth by reducing a hair growth inhibitor.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

Topical glucocorticoids thin the skin and change collagen structure.

Brodalumab is more effective than ustekinumab in treating psoriasis.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Combining fluticasone propionate and UV-A is more effective for vitiligo than using either alone.

Fexofenadine reduces discomfort but doesn't significantly improve hair regrowth in Alopecia Areata treatment.

Elental is a good long-term treatment for Crohn's disease, similar to 6-mercaptopurine but with fewer side effects.

A 300 mg monthly pulse of prednisolone effectively and safely treats widespread alopecia areata.

Zusanli acupoint injection of metoclopramide effectively treats functional dyspepsia.

Both brands of biotin and dexpanthenol injections improved hair loss, with Bayer also increasing the ratio of thick to thin hairs.

Medium-dose prednisolone pulse therapy is effective and safe for multifocal alopecia areata but not for more severe forms.

High-dose mizoribine effectively controls symptoms in adolescents with lupus while reducing steroid use, with manageable side effects.

Baricitinib significantly improved hair regrowth and skin condition in a 14-year-old with alopecia areata and atopic dermatitis.

Adequate steroid treatment needed to limit bone loss in PMR patients.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Sequential therapy with dupilumab and baricitinib improved hair regrowth and atopic dermatitis in a child without adverse reactions.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Long-term Imiquimod treatment causes initial skin inflammation that lessens over time, and topical corticosteroids reduce this inflammation and cytokines in a mouse model of psoriasis.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Bicalutamide mesotherapy may help with hair loss and seborrhea but needs more research.

Probiotics with Lactobacillus reuteri improve IBS symptoms in children.

Bazhengsan reduces inflammation and tissue growth in chronic prostatitis.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Adalimumab helped control a child's severe eye disease when other treatments failed.